| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |